
Andrew M. Schechter
Supervisory Patent Examiner (ID: 14193, Phone: (571)272-2302 , Office: P/2857 )
| Most Active Art Unit | 2857 |
| Art Unit(s) | 2883, 2871, 2857 |
| Total Applications | 983 |
| Issued Applications | 394 |
| Pending Applications | 244 |
| Abandoned Applications | 342 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18995842
[patent_doc_number] => 11912669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-02-27
[patent_title] => Small molecule compound
[patent_app_type] => utility
[patent_app_number] => 17/537142
[patent_app_country] => US
[patent_app_date] => 2021-11-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 23
[patent_no_of_words] => 9740
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17537142
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/537142 | Small molecule compound | Nov 28, 2021 | Issued |
Array
(
[id] => 17460213
[patent_doc_number] => 20220073518
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => FUSED RING DERIVATIVE HAVING MGAT-2 INHIBITORY ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 17/525010
[patent_app_country] => US
[patent_app_date] => 2021-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17525010
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/525010 | Fused ring derivative having MGAT-2 inhibitory activity | Nov 11, 2021 | Issued |
Array
(
[id] => 18844405
[patent_doc_number] => 20230406809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => METHOD OF PREPARING HETEROGENEOUS LINEAR CARBONATE USING AMINE-BASED COMPOUND CATALYST
[patent_app_type] => utility
[patent_app_number] => 18/254010
[patent_app_country] => US
[patent_app_date] => 2021-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3215
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18254010
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/254010 | METHOD OF PREPARING HETEROGENEOUS LINEAR CARBONATE USING AMINE-BASED COMPOUND CATALYST | Nov 3, 2021 | Pending |
Array
(
[id] => 18842605
[patent_doc_number] => 20230405009
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => METHODS FOR TREATING HEMATOLOGIC MALIGNANCIES WITH AMINO-PYRROLOPYRIMIDINONE COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 18/250404
[patent_app_country] => US
[patent_app_date] => 2021-11-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16396
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250404
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250404 | METHODS FOR TREATING HEMATOLOGIC MALIGNANCIES WITH AMINO-PYRROLOPYRIMIDINONE COMPOUNDS | Nov 1, 2021 | Pending |
Array
(
[id] => 18808815
[patent_doc_number] => 20230383149
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-30
[patent_title] => COORDINATION COMPOUND AND LIGHT ABSORBER COMPRISING SAME
[patent_app_type] => utility
[patent_app_number] => 18/031597
[patent_app_country] => US
[patent_app_date] => 2021-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23445
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 302
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18031597
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/031597 | COORDINATION COMPOUND AND LIGHT ABSORBER COMPRISING SAME | Oct 21, 2021 | Pending |
Array
(
[id] => 17503373
[patent_doc_number] => 20220096475
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-31
[patent_title] => METHOD FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION
[patent_app_type] => utility
[patent_app_number] => 17/507295
[patent_app_country] => US
[patent_app_date] => 2021-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3587
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17507295
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/507295 | METHOD FOR TREATING SARCOIDOSIS-ASSOCIATED PULMONARY HYPERTENSION | Oct 20, 2021 | Abandoned |
Array
(
[id] => 17428280
[patent_doc_number] => 20220055988
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/484876
[patent_app_country] => US
[patent_app_date] => 2021-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19685
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -56
[patent_words_short_claim] => 272
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17484876
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/484876 | DUAL FUNCTION MOLECULES FOR HISTONE DEACETYLASE INHIBITION AND ATAXIA TELANGIECTASIA MUTATED ACTIVATION AND METHODS OF USE THEREOF | Sep 23, 2021 | Abandoned |
Array
(
[id] => 19969650
[patent_doc_number] => 12338242
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-06-24
[patent_title] => TYK2 inhibitors and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/448482
[patent_app_country] => US
[patent_app_date] => 2021-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44658
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 108
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17448482
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/448482 | TYK2 inhibitors and uses thereof | Sep 21, 2021 | Issued |
Array
(
[id] => 17480453
[patent_doc_number] => 20220087957
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-24
[patent_title] => Targeting mitochondrial dynamics by mitochondrial fusion promoter M1 as a treatment strategy for nervous system injury
[patent_app_type] => utility
[patent_app_number] => 17/448215
[patent_app_country] => US
[patent_app_date] => 2021-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8408
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 119
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17448215
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/448215 | Targeting mitochondrial dynamics by mitochondrial fusion promoter M1 as a treatment strategy for nervous system injury | Sep 20, 2021 | Issued |
Array
(
[id] => 18210186
[patent_doc_number] => 20230056447
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-02-23
[patent_title] => TYK2 INHIBITORS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/447648
[patent_app_country] => US
[patent_app_date] => 2021-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 296280
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17447648
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/447648 | TYK2 INHIBITORS AND USES THEREOF | Sep 13, 2021 | Abandoned |
Array
(
[id] => 20171704
[patent_doc_number] => 12390424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-19
[patent_title] => Sulfur (VI) fluoride compounds and methods for the preparation thereof
[patent_app_type] => utility
[patent_app_number] => 17/471936
[patent_app_country] => US
[patent_app_date] => 2021-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 37
[patent_no_of_words] => 39151
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17471936
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/471936 | Sulfur (VI) fluoride compounds and methods for the preparation thereof | Sep 9, 2021 | Issued |
Array
(
[id] => 18147367
[patent_doc_number] => 20230021224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHODS AND COMPOSITIONS OF INHIBITING DCN1-UBC12 INTERACTION
[patent_app_type] => utility
[patent_app_number] => 17/470678
[patent_app_country] => US
[patent_app_date] => 2021-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 50962
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 161
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17470678
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/470678 | Methods and compositions of inhibiting DCN1-UBC12 interaction | Sep 8, 2021 | Issued |
Array
(
[id] => 17441696
[patent_doc_number] => 20220062201
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-03
[patent_title] => COMPOSITIONS AND METHODS OF TREATMENT FOR TINEA PEDIS
[patent_app_type] => utility
[patent_app_number] => 17/466770
[patent_app_country] => US
[patent_app_date] => 2021-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5172
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17466770
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/466770 | Compositions and methods of treatment for tinea pedis | Sep 2, 2021 | Issued |
Array
(
[id] => 18707535
[patent_doc_number] => 20230330111
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => ACTIVE AGENT COMBINATION FOR TREATMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 18/043491
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11938
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 241
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18043491
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/043491 | ACTIVE AGENT COMBINATION FOR TREATMENT OF CANCER | Aug 26, 2021 | Abandoned |
Array
(
[id] => 18144814
[patent_doc_number] => 20230018666
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-01-19
[patent_title] => METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND, AND DEUTERATED REACTIVE COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 17/779920
[patent_app_country] => US
[patent_app_date] => 2021-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12796
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17779920
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/779920 | METHOD FOR PREPARING DEUTERATED AROMATIC COMPOUND, AND DEUTERATED REACTIVE COMPOSITION | Aug 26, 2021 | Pending |
Array
(
[id] => 19401283
[patent_doc_number] => 12075697
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-08-27
[patent_title] => Inert solution-processable molecular chromophores for organic electronic devices
[patent_app_type] => utility
[patent_app_number] => 17/412135
[patent_app_country] => US
[patent_app_date] => 2021-08-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 22122
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17412135
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/412135 | Inert solution-processable molecular chromophores for organic electronic devices | Aug 24, 2021 | Issued |
Array
(
[id] => 20386550
[patent_doc_number] => 12486267
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-12-02
[patent_title] => Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis
[patent_app_type] => utility
[patent_app_number] => 18/042036
[patent_app_country] => US
[patent_app_date] => 2021-08-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 43824
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 196
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18042036
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/042036 | Imidazo[1,2-A]pyridine and [1,2,4]triazolo[1,5-A]pyridine derivatives as TLR9 inhibitors for the treatment of fibrosis | Aug 17, 2021 | Issued |
Array
(
[id] => 18895152
[patent_doc_number] => 20240010637
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-01-11
[patent_title] => PROCESS FOR THE PREPARATION OF PYRIDAZINONE DERIVATIVES
[patent_app_type] => utility
[patent_app_number] => 18/041593
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11272
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041593
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041593 | PROCESS FOR THE PREPARATION OF PYRIDAZINONE DERIVATIVES | Aug 12, 2021 | Pending |
Array
(
[id] => 18567044
[patent_doc_number] => 20230257373
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => QUORUM SENSING INHIBITORS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 18/041241
[patent_app_country] => US
[patent_app_date] => 2021-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18898
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -40
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041241
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041241 | QUORUM SENSING INHIBITORS AND METHODS OF USE | Aug 12, 2021 | Pending |
Array
(
[id] => 18955067
[patent_doc_number] => 20240043394
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => PROTEASOME ENHANCERS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/041193
[patent_app_country] => US
[patent_app_date] => 2021-08-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22789
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -15
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18041193
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/041193 | PROTEASOME ENHANCERS AND USES THEREOF | Aug 9, 2021 | Pending |